Non-ionic Iodine Contrast Media Market was valued at USD 3.75 Billion in 2022 and is projected to reach USD 5.65 Billion by 2030, growing at a CAGR of 5.30% from 2024 to 2030.
Looking ahead, from 2023 to 2033, the Non-ionic Iodine Contrast Media market is set to witness substantial shifts driven by several factors. Advances in healthcare infrastructure, particularly in emerging markets, will lead to an expansion in the availability of medical imaging services, subsequently increasing the demand for non-ionic iodine contrast media. Furthermore, the demand is expected to rise due to the growing prevalence of cardiovascular diseases, cancer, and neurological disorders, all of which rely heavily on imaging procedures for diagnosis and monitoring. As patients' awareness of diagnostic imaging increases, coupled with advancements in imaging technology, non-ionic iodine contrast agents will continue to play a pivotal role in ensuring accurate diagnostics and better patient outcomes.
Moreover, the growing trend of outpatient imaging centers and the adoption of AI-driven imaging systems will further augment the market. Companies are also focusing on the development of advanced contrast agents with enhanced safety profiles and improved efficacy in terms of contrast resolution and dose efficiency. Additionally, the COVID-19 pandemic significantly impacted the market dynamics during 2020-2021, with delays in elective procedures and a decline in hospital visits, but recovery is expected from 2023 onwards as the global healthcare sector rebounds. Furthermore, increasing collaborations and partnerships between pharmaceutical companies and imaging technology firms are expected to introduce more innovative products in the market, potentially opening up new opportunities for growth.
Get an In-Depth Research Analysis of the Global Non-ionic Iodine Contrast Media Market Size And Forecast [2025-2032]
The Non-ionic Iodine Contrast Media market, which plays a critical role in medical imaging, saw significant growth from 2018 to 2022. As a vital component in imaging procedures such as CT scans, MRIs, and angiographies, the demand for iodine contrast media surged during this period due to an increasing number of diagnostic procedures, advancements in imaging technologies, and a rise in healthcare accessibility. Non-ionic iodine contrast agents, known for their lower toxicity and better image clarity, experienced high adoption rates across hospitals and imaging centers worldwide. In 2020, the market was valued at over USD 4 billion and was projected to continue growing at a steady rate of around 5-6% annually due to the increasing prevalence of chronic diseases, rising geriatric population, and technological progress in diagnostic imaging equipment.
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Sanochemia
Tyco Healthcare
Imax
Grupo Juste
Daiichi Sankyo
Takeda
Fuji Pharma
Towaseiyaku
Hikari Pharmaceutical
Consentis Diagnostics GmbH
T2Pharma
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Non-ionic Iodine Contrast Media Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Non-ionic Iodine Contrast Media Market
Hospitals
Clinics
Based on Types the Market is categorized into Below types that held the largest Non-ionic Iodine Contrast Media market share In 2023.
Iohexol
Iodixanol
Iopamidol
Ioversol
Others
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Non-ionic Iodine Contrast Media Market Research Analysis
1. Introduction of the Global Non-ionic Iodine Contrast Media Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Non-ionic Iodine Contrast Media Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Non-ionic Iodine Contrast Media Market, By Type
6. Global Non-ionic Iodine Contrast Media Market, By Application
7. Global Non-ionic Iodine Contrast Media Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Non-ionic Iodine Contrast Media Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/